CH529741A - Verfahren zur Herstellung von 4,20,22-Bufatrienolidrhamnosidacylaten - Google Patents

Verfahren zur Herstellung von 4,20,22-Bufatrienolidrhamnosidacylaten

Info

Publication number
CH529741A
CH529741A CH13570A CH13570A CH529741A CH 529741 A CH529741 A CH 529741A CH 13570 A CH13570 A CH 13570A CH 13570 A CH13570 A CH 13570A CH 529741 A CH529741 A CH 529741A
Authority
CH
Switzerland
Prior art keywords
drhamnoside
bufatrienolide
acylates
preparation
drhamnoside acylates
Prior art date
Application number
CH13570A
Other languages
English (en)
Inventor
Nat Steidle Walter Dr Rer
Nat Kubinyl Hugo Dr Rer
Nat Goerlich Bruno Dr Rer
Original Assignee
Knoll Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19691900898 external-priority patent/DE1900898B2/de
Priority claimed from DE19691927908 external-priority patent/DE1927908C3/de
Application filed by Knoll Ag filed Critical Knoll Ag
Publication of CH529741A publication Critical patent/CH529741A/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A61K31/585—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin containing lactone rings, e.g. oxandrolone, bufalin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B60—VEHICLES IN GENERAL
    • B60R—VEHICLES, VEHICLE FITTINGS, OR VEHICLE PARTS, NOT OTHERWISE PROVIDED FOR
    • B60R25/00—Fittings or systems for preventing or indicating unauthorised use or theft of vehicles
    • B60R25/01—Fittings or systems for preventing or indicating unauthorised use or theft of vehicles operating on vehicle systems or fittings, e.g. on doors, seats or windscreens
    • B60R25/02—Fittings or systems for preventing or indicating unauthorised use or theft of vehicles operating on vehicle systems or fittings, e.g. on doors, seats or windscreens operating on the steering mechanism
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J19/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 by a lactone ring

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mechanical Engineering (AREA)
  • Cardiology (AREA)
  • Molecular Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Steroid Compounds (AREA)
CH13570A 1969-01-09 1970-01-07 Verfahren zur Herstellung von 4,20,22-Bufatrienolidrhamnosidacylaten CH529741A (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19691900898 DE1900898B2 (de) 1969-01-09 1969-01-09 Delta hoch 4.20.22 - bufatrienolidrhamnosidmono - und diacetate, verfahren zu deren herstellung u. diese enthaltende arzneimittel
DE19691927908 DE1927908C3 (de) 1969-05-31 1969-05-31 Verfahren zur Herstellung von A4·20·22 -Bufatrienolidrhamnosid- 3'-acylaten, einige dieser Verbindungen sowie diese enthaltende Arzneimittel

Publications (1)

Publication Number Publication Date
CH529741A true CH529741A (de) 1972-10-31

Family

ID=25756815

Family Applications (1)

Application Number Title Priority Date Filing Date
CH13570A CH529741A (de) 1969-01-09 1970-01-07 Verfahren zur Herstellung von 4,20,22-Bufatrienolidrhamnosidacylaten

Country Status (12)

Country Link
US (1) US3743633A (de)
JP (1) JPS526988B1 (de)
AU (1) AU1016070A (de)
BE (1) BE744226A (de)
CH (1) CH529741A (de)
FR (1) FR2034460B1 (de)
GB (1) GB1286232A (de)
IL (1) IL33658A0 (de)
NL (1) NL7000296A (de)
SE (1) SE372264B (de)
SU (1) SU425392A3 (de)
YU (1) YU33975B (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3987031A (en) * 1970-12-23 1976-10-19 Boehringer Ingelheim Gmbh Acyl derivatives of proscillaridin a
DE2063406C3 (de) * 1970-12-23 1978-05-03 C.H. Boehringer Sohn, 6507 Ingelheim Acylderivate des Proscillaridin A, Verfahren zu deren Herstellung und diese enthaltende Präparate
DE2437693A1 (de) * 1974-08-05 1976-02-26 Boehringer Sohn Ingelheim Neue proscillaridinderivate und verfahren zu deren herstellung
JPS53153191U (de) * 1977-05-10 1978-12-02
JPS5520758U (de) * 1978-07-28 1980-02-09
GB9502540D0 (en) * 1995-02-09 1995-03-29 Zeneca Ltd Compounds
GB9618952D0 (en) 1996-09-11 1996-10-23 Sandoz Ltd Process

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1568015A1 (de) * 1966-06-18 1970-02-12 Asta Werke Ag Chem Fab Neue Acylderivate des Proscillaridin A und Verfahren zu ihrer Herstellung

Also Published As

Publication number Publication date
GB1286232A (en) 1972-08-23
JPS526988B1 (de) 1977-02-26
YU33975B (en) 1978-09-08
FR2034460B1 (de) 1974-08-09
AU1016070A (en) 1971-07-15
FR2034460A1 (de) 1970-12-11
SU425392A3 (ru) 1974-04-25
BE744226A (fr) 1970-07-09
SE372264B (de) 1974-12-16
NL7000296A (de) 1970-07-13
US3743633A (en) 1973-07-03
IL33658A0 (en) 1970-03-22
YU326469A (de) 1978-02-28

Similar Documents

Publication Publication Date Title
AT299142B (de) Verfahren zur Herstellung von 2,2-Dimethylpropandiol-(1,3)
CH546241A (de) Verfahren zur herstellung von 6,7-benzomorphanen.
CH580082A5 (de) Verfahren zur herstellung von 2,4-diamino-5-benzylpyrimidinen.
CH550177A (de) Verfahren zur herstellung von substituierten n-aminoalkyl-arylamino-imidazolinen-(2).
CH553181A (de) Verfahren zur herstellung von 4-heterosubstituierten azetidinonen-(2).
CH542801A (de) Verfahren zur Herstellung von 1,1-Dihydroperfluoralkanolen
AT300364B (de) Verfahren zur Herstellung von linearen 3,3,3-Trifluorpropylmethylpolysiloxanen
CH535249A (de) Verfahren zur Herstellung von 2-Amino-4-hydroxy-6-hydroxymethyl-7,7-dimethyl-7,8-dihydropteridin
CH531523A (de) Verfahren zur Herstellung von 2,6-Dichlor-4-heterocyclyl-pyridin-3,5-dicarbonitrilen
CH529741A (de) Verfahren zur Herstellung von 4,20,22-Bufatrienolidrhamnosidacylaten
CH531477A (de) Verfahren zur Herstellung von 1,3-Propandiol-Derivaten
AT287665B (de) Verfahren zur Herstellung von 2,2-Dimethyl-3-hydroxypropanal
CH517110A (de) Verfahren zur Herstellung von 2,1,3-Benzothiadiazolen
CH539015A (de) Verfahren zur Herstellung von 1,3-Diacetoxy-2-methylen-propan
CH537401A (de) Verfahren zur Herstellung von 1,2-Dihydropyrido-(2,3-d)-pyrimidin-2-onen
CH524556A (de) Verfahren zur Herstellung von 2,3,6-Trimethylhydrochinon
CH537968A (de) Verfahren zur Herstellung von 2,2'-Diacylamino-1,1'-dianthrachinonylen
CH537366A (de) Verfahren zur Herstellung von 4-Aminoalkyl-bicyclo-(2,2,2)-octan-1-carbonsäuren
CH548966A (de) Verfahren zur herstellung von 1,2-cycloalkyliden-3,5,6tri-o-benzyl-d-glucofuranosen.
CH520143A (de) Verfahren zur Herstellung von 4,5,6,7-Tetrahydrobenzimidazolen
CH532569A (de) Verfahren zur Herstellung von 6-Alkoxy-5,6-dihydro-4H-pyranen
CH516564A (de) Verfahren zur Herstellung von 4,5,6-Tri-chlorpyrimidinen
CH536854A (de) Verfahren zur Herstellung von 6,7 Methylendioxycinnolin-3-carbonitrilen
CH535760A (de) Verfahren zur Herstellung von 4,5,6,7-Tetrahydro-cyclopenta-1,3-dioxinonen-(4)
AT303277B (de) Verfahren zur herstellung von neuem 9 alpha-fluor-16-fluormethylenprednisolon-21-oenanthat

Legal Events

Date Code Title Description
PL Patent ceased